附有多媒體內容的新聞
-
Higlobe Surpasses $100 Million in Annualized Volume, Offering Instant Transfers with the Lowest-cost Guaranteed for Overseas Contractors and SMBs Paid by U.S. Clients
-
Renesas Introduces New RX261/RX260 Group MCUs with Outstanding Power Efficiency, Advanced Touch Functions and Robust Security
-
Fujita Health University and BostonGene Expand Access to Genomic Cancer Testing with Tumor Portrait™ at Haneda Clinic
-
A HemoHim gyártója, a Kolmar BNH "NAI" besorolást kapott az FDA-tól
-
Výrobce přípravku HemoHim společnost Kolmar BNH získala od amerického úřadu FDA klasifikaci NAI
-
Kioxia dévoilera des technologies de mémoire émergentes à l'occasion de l'IEDM 2024
-
Jumio Leads With Innovation by Announcing Over 300 Patents and Patent Applications
-
Kolmar BNH, fabrikant van HemoHim, ontvangt NAI-classificatie van de Amerikaanse FDA
-
Fabricante de HemoHim, Kolmar BNH, recebe classificação NAI da FDA dos EUA
-
Hytera to Revolutionize Mobile Workforce Communication by Launching P5 Series PoC Radio
-
Producent preparatu HemoHim, firma Kolmar BNH, z klasyfikacją NAI od amerykańskiej Agencji Żywności i Leków (FDA)
-
P3 Group und FPT Software gründen Joint Venture P3 Vietnam Ltd. – Umsetzungsstarke Partnerschaft für strategische Großprojekte
-
P3 Group and FPT Establish Joint Venture P3 Vietnam Ltd. – A Powerful Partnership for Strategic Large-Scale Projects
-
Kioxia stellt auf der IEDM 2024 neue Speichertechnologien vor
-
Kolmar BNH, produttore di HemoHim, ottiene la classificazione NAI dalla FDA statunitense